Brevetti EPO No.3644970 2022.02.09
Brevetti EPO
(10) Registration Number and Date
2022000191 2022.05.05
Status
Registered
(180) Expiration Date
(20) Filing Number and Date
SM /T/2022/000191 2018.06.29
(40) Publication Number and Date
SM /T/2022/000191 2022.05.05
(30) Priority Details
EP 17305853
2017.07.03
US 201762527684 P
2017.06.30
(51) IPC Classes
(71/73) Applicant
(IT) ACROTECH BIOPHARMA LLC : 279 Princeton Hightstown Road, East Windsor, NJ 08520, US
(72) Inventor
(IT) PIVETTE, Perrine : 171 Rue Paul Vaillant Couturier, 94140 Alfortville, FR
(IT) YATES, Ian : 64550 Research Road, BendOregon 97701, US
(IT) LEMARCHAND, Caroline : 11 bis rue Maison Dieu F, 75014 Paris, FR
(74) Representative Name
(IT) MOSCATELLI, Filippo : Via F. Montebello, 5, 47892 Acquaviva RSM, SM
(54) Title
(IT) NUOVE FORMULAZIONI ORALI DI BELINOSTAT
(EN) NEW ORAL FORMULATIONS OF BELINOSTAT
(57) Abstract
(58) Citations
Document Type Date Action
Traduzione 2022.07.21
Event NameDateStatus
Filing2018.06.29Filed
Brevetto EPO concesso2022.05.05Published
Ricevuta pagamento annualita 52022.06.14Payed
Ricevuta pagamento annualita 62023.06.05Payed
Ricevuta pagamento annualita 72024.06.13Payed